These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22955957)

  • 21. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y; Wu T; Hu X; Wang T
    Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
    Pennati GV; Da Re C; Messineo I; Bonaiuti D
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):381-7. PubMed ID: 25358636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB; Rosales RL; Dressler D
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin type A for upper limb spasticity after stroke.
    Shaw L; Rodgers H
    Expert Rev Neurother; 2009 Dec; 9(12):1713-25. PubMed ID: 19951131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
    Bakheit AM; Pittock S; Moore AP; Wurker M; Otto S; Erbguth F; Coxon L
    Eur J Neurol; 2001 Nov; 8(6):559-65. PubMed ID: 11784339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke.
    Gordon MF; Brashear A; Elovic E; Kassicieh D; Marciniak C; Liu J; Turkel C;
    Neurology; 2004 Nov; 63(10):1971-3. PubMed ID: 15557529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Dosage of Botulinum Toxin Type A in Adult Subjects with Spasticity Following Acquired Central Nervous System Damage: Where Are We at?
    Intiso D; Simone V; Bartolo M; Santamato A; Ranieri M; Gatta MT; Di Rienzo F
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32397674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke.
    Santamato A; Panza F; Filoni S; Ranieri M; Solfrizzi V; Frisardi V; Dellomonaco A; Amoruso MT; Amoruso L; Kehoe PG; Megna M; Fiore P
    Brain Inj; 2010; 24(9):1108-12. PubMed ID: 20569045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SBOTE study: extracorporeal shock wave therapy versus electrical stimulation after botulinum toxin type a injection for post-stroke spasticity-a prospective randomized trial.
    Santamato A; Notarnicola A; Panza F; Ranieri M; Micello MF; Manganotti P; Moretti B; Fortunato F; Filoni S; Fiore P
    Ultrasound Med Biol; 2013 Feb; 39(2):283-91. PubMed ID: 23245824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does botulinum toxin improve the function of the patient with spasticity after stroke?
    Cardoso E; Pedreira G; Prazeres A; Ribeiro N; Melo A
    Arq Neuropsiquiatr; 2007 Sep; 65(3A):592-5. PubMed ID: 17876396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IncobotulinumtoxinA Efficacy/Safety in Upper-Limb Spasticity in Pediatric Cerebral Palsy: Randomized Controlled Trial.
    Dabrowski E; Chambers HG; Gaebler-Spira D; Banach M; Kaňovský P; Dersch H; Althaus M; Geister TL; Heinen F
    Pediatr Neurol; 2021 Oct; 123():10-20. PubMed ID: 34339951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis.
    Baricich A; Grana E; Carda S; Santamato A; Cisari C; Invernizzi M
    J Neural Transm (Vienna); 2015 Sep; 122(9):1283-7. PubMed ID: 25724294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial.
    Do KH; Chun MH; Paik NJ; Park YG; Lee SU; Kim MW; Kim DK
    Clin Rehabil; 2017 Sep; 31(9):1179-1188. PubMed ID: 28118733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
    Marciniak C; McAllister P; Walker H; Brashear A; Edgley S; Deltombe T; Khatkova S; Banach M; Gul F; Vilain C; Picaut P; Grandoulier AS; Gracies JM;
    PM R; 2017 Dec; 9(12):1181-1190. PubMed ID: 28625615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity.
    Santamato A; Panza F
    Drugs; 2017 Sep; 77(13):1413-1422. PubMed ID: 28726023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of botulinum toxin for spasticity after spinal cord injury.
    Marciniak C; Rader L; Gagnon C
    Am J Phys Med Rehabil; 2008 Apr; 87(4):312-7; quiz 318-20, 329. PubMed ID: 18356622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.